Research Peptides

Ac-KPV

Ac-KPV-NH2 is a potent anti-inflammatory peptide that has shown promise in a number of disease conditions. The most active research is in the treatment of inflammatory bowel disease where the peptide has showed substantial promise. Research in wound healing also reveals that Ac-KPV-NH2 and other alpha-MSH derivatives may offer a host of benefits that speed wound healing, reduce infection, fight inflammation, and lead to better cosmetic results. Ac-KPV-NH2 and similar peptides could become mainstays not just in wound healing, but in scar reduction following surgery.

KPV

Formula

C₁₇H₃₂N₆O₄

MW

384.48 g/mol

Purity

99% HPLC

Length

3 aa

Ac-KPV-NH2 is a potent anti-inflammatory peptide that has shown great promise for use in the treatment of various diseases.

Cagrilintide

Cagrilintide is a long-acting analogue of amylin, a naturally occurring peptide that is released in conjunction with insulin. Cagrilintide has shown promise in animal trials as a treatment for obesity and type 2 diabetes. It has been studied for benefits not just in type 2 diabetes, but for liver damage, alcohol-related liver disease, and heart/blood vessel disease. There is some speculation about the role of this peptide in Alzheimer’s disease as well, but no research has been published in that particular sub-domain, yet. Many trials, however, have looked at the combination of cagrilintide and semaglutide in the treatment of obesity and type 2 diabetes. The two proteins appear to work synergistically to provide more robust and more permanent weight loss effects. It is important to note that while preclinical studies suggest promising therapeutic potential, clinical trials in humans are limited. Further research needs to be done to determine the efficacy and safety profiles.

Formula

C₁₉₄H₃₁₂N₅₄O₅₉S₂

MW

4409.01 g/mol

Purity

99% HPLC

Length

37 aa

appetite regulation, satiety, weight management, and energy metabolism.

PT-141

PT-141, also called Bremelanotide (generic clinical name), is a heavily modified synthetic derivative of alpha-melanocyte-stimulating hormone. It has been tested in clinical trials as a treatment for both male/female hypoactive sexual desire disorder and acute hemorrhage. PT-141 is an agonist for the melanocortin-4 and melanocortin-1 receptors. Research shows that it promotes sexual arousal and stimulates the immune system.

Formula

C₅₀H₆₈N₁₄O₁₀

MW

1025.18 g/mol

Purity

99% HPLC

Length

7 aa

Research on melanocortin receptors, the regulation of sexual desire, and neuroendocrinology.